CME · Q2 2025 Earnings
BullishCME Group
Reported July 23, 2025
30-second summary
Volume hit an all-time high of 30.2M average daily contracts (+16% YoY) across all six asset classes, pushing revenue to $1.69B (+10.4% YoY) and adjusted EPS to a record $2.96 (+16%). Management is framing tariffs, geopolitical risk, and record sovereign debt not as cyclical noise but as a structural demand engine — and the numbers, particularly +57% new retail traders and record international ADV, back the narrative. The NASDAQ index license extension through 2039 removes the single largest overhang on the equity-index franchise.
Headline numbers
EPS
Q2 FY2025
$2.96
Revenue
Q2 FY2025
$1.69B
+10.4% YoY
Operating margin
Q2 FY2025
66.7%
Key financials
Q2 FY2025| Metric | Q2 FY2025 | YoY |
|---|---|---|
| Revenue | $1.69B | +10.4% |
| EPS | $2.96 | — |
| Operating margin | 66.7% | — |
Guidance
Prior quarter data unavailable — comparison not possible.
Segment performance
Q2 FY2025| Segment | Q2 FY2025 | YoY |
|---|---|---|
| Clearing and transaction fees | $1.388B | +11.1% |
| Market data and information services | $0.198B | +13.3% |
| Other | $0.106B | -1.6% |
Capital & returns
Q2 FY2025| Segment | Q2 FY2025 |
|---|---|
| Total debt | $3.4 billion |
Other KPIs
Q2 FY2025| Segment | Q2 FY2025 |
|---|---|
| Average Daily Volume (ADV) | 30.2 million contracts |
| ADV growth year-over-year | 16% |
| Average Rate Per Contract (RPC) | $0.690 |
| CME Globex ADV | 28.1 million contracts |
| Micros ADV | 4.1 million contracts |
| New retail traders growth | +57% year-over-year |
| Operating margin | 66.7% |
Management tone
The call's defining shift is that volatility is no longer something CME benefits from — it is something clients now structurally need CME to absorb. The hedging quote: "In an environment of heightened headline risk and macro uncertainties, clients are increasingly choosing the transparency and capital efficiency of our essentially cleared benchmark products." That reframing turns a cyclical story into a secular one and explains why management is willing to anchor growth to retail expansion and international penetration rather than rate volatility.
Retail moved from a tertiary theme to a headline metric. Management led with "over 90,000 new retail traders participated in our markets for the first time, a 56% increase versus the same period last year" and produced supporting cross-sell data (micro Bitcoin +94%, micro Ether +212%, retail RPC up 7% to $0.349). The level of granularity — broker-channel partnerships, 100+ client events, five consecutive quarters of double-digit acquisition — signals that retail has graduated from experiment to operating priority.
The NASDAQ license extension is the most quietly important disclosure on the call. "We were able to announce a 10-year extension a CME Group's exclusive license to offer futures and options on futures based on the NASDAQ 100 and other NASDAQ indexes. This license will go through 2039." Equity-index ADV grew 13% in Q2 FY2025 and is the highest-RPC complex; removing renewal risk through 2039 at existing economics resolves what was the largest single contract-risk overhang in the franchise.
International went from "growing segment" to record-setting. EMEA and APAC each hit all-time highs (+15% and +30% respectively) and combined now represent 9.2M ADV — nearly a third of total volume. The tariff cycle that began in April was explicitly cited as driving sustained, not transient, EMEA/APAC activity.
Confidence in Q&A was notably higher than typical CME calls except on one topic: 24/7 trading. Terry Duffy's hedge that the timeline "could be 10 years, 20 years, or 2 years — I don't know" stood out against the precise metrics offered everywhere else, suggesting management has no near-term plan and wants to avoid being pinned to one.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Owen Lau · Oppenheimer
What macro backdrop and key drivers (interest rates, commodities, crypto) can sustain strong hedging activities in H2?
Management acknowledged difficulty predicting volumes but highlighted global risks: record debt levels in US and Europe, geopolitical tensions (Russia-Ukraine, Israel-Palestine), and policy uncertainty (tariffs). These create risk management needs across asset classes. No specific driver identified as dominant; multiple factors could drive hedging demand.
Brian Bedell · Deutsche Bank
Retail growth metrics: how are 90,000 new traders measured, new broker sources, cross-asset participation? Crypto strategy: perpetuals, tokenization, acquisitions?
90,000 new traders represent 56% YoY growth, 5th consecutive quarter of double-digit retail acquisition. Growth driven by partnerships with new futures brokers, diverse products, education. Retail shows cross-asset migration (crypto 94% micro Bitcoin, 212% micro Ether growth). On crypto: CME is 'fast follower' not first mover. Perpetuals face US legal barriers; cash-settled products more conducive. No perpetual plans announced.
Chris Allen · Citi
Capital deployment priorities: buybacks vs dividends given cash balance and closing loss rate in H2? Inorganic growth opportunities?
Capital deployment strategy unchanged: opportunistic share repurchase program combined with variable dividend structure, dependent on market activity. Inorganic M&A remains challenging in exchange space; more selective approach. Pursuing growth through joint ventures and commercial agreements (NASDAQ extension announced) rather than pure M&A.
Eli Abuhudan · Bank of America
Impact of tariffs on physical commodities business? Have basis differentials with European alternatives affected commercial channel trading?
Tariffs creating short/long-term dislocations and cost basis differentials requiring risk management. Results in increased volume and record activity across APAC (up 40%) and EMEA (up 22%). Basis shifts reflected in record EFP (exchange of physical) activity. Options saw particular strength. Record volumes in metals and energy sustained through June. Tariff-driven basis risk is opportunity for both commercial hedgers and speculators.
Ken Worthington · JPMorgan
Impact of new cash collateral requirements (April 1 implementation, 30% soft minimum, 10 bps charge)? Average collateral balances?
Total collateral Q2 averaged $316B (up from $290B Q1): $133B cash, $145B non-cash. Cash posted at ~48% vs 30% soft minimum, elevated due to Q2 volatility spike. Expected to normalize toward 30% target as year progresses. July showing steady cash (~$132B) but higher non-cash ($153B), suggesting gradual normalization. Charge impact not quantified separately.
What to watch into next quarter
Cash collateral normalization — Q2 FY2025 cash share at 48% vs 30% target inflated near-term clearing revenue. Watch whether the mix migrates toward 30% in Q3 FY2025 and what the dollar impact on non-trading revenue is.
Retail trader cohort retention — five straight quarters of double-digit acquisition is a vintage problem in disguise. Watch whether trailing-cohort active counts and rate-per-contract hold up, not just new-trader gross adds.
ADV in H2 FY2025 against the 30.2M Q2 FY2025 baseline — Q2 FY2025 was the first quarter ever above 30M, partly tariff-driven. A reversion to 27-28M would still be growth but would dent the "structural demand" narrative.
Crypto complex monetization — $26B notional and 232K July contracts are headline-grabbing but RPC and revenue contribution remain unstated. Look for explicit revenue disclosure if growth continues.
FY2025 adjusted opex tracking against the $1.635B guide — first-half spending pace will tell whether the 3% growth target absorbs continued international and retail investment or requires upward revision.
International ADV mix — EMEA +15% and APAC +30% are now meaningful enough that any reversal would be visible at the consolidated level. Watch for sustainment versus tariff-cycle dependence.
Sources
- CME Group Q2 FY2025 Press Release (Exhibit 99.1), SEC filing, July 23, 2025: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000176/exhibit9916302025.htm
- CME Group Q2 FY2025 earnings call commentary and Q&A (as provided in extraction inputs)
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.